509
Participants
Start Date
October 31, 2007
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
pregabalin
300, 450, 600 mg/day administered orally, BID until seizure control/improvement or intolerable side effects
levetiracetam
1000, 2000, 3000 mg/day administered orally, BID until seizure control/improvement or intolerable side effects
Pfizer Investigational Site, Barranquilla
Pfizer Investigational Site, Bogota
Pfizer Investigational Site, Taichung
Pfizer Investigational Site, Tainan City
Pfizer Investigational Site, Kaohsiung City
Pfizer Investigational Site, Tondo
Pfizer Investigational Site, Manila
Pfizer Investigational Site, Caracas
Pfizer Investigational Site, Quezon City
Pfizer Investigational Site, Sofia
Pfizer Investigational Site, Makati City
Pfizer Investigational Site, Sofia
Pfizer Investigational Site, Pernik
Pfizer Investigational Site, Plovdiv
Pfizer Investigational Site, Cebu City
Pfizer Investigational Site, Davao City
Pfizer Investigational Site, Athens
Pfizer Investigational Site, Córdoba
Pfizer Investigational Site, Distrito Federal
Pfizer Investigational Site, Girona
Pfizer Investigational Site, Donostia / San Sebastian
Pfizer Investigational Site, Hamburg
Pfizer Investigational Site, Příbram
Pfizer Investigational Site, Toulouse
Pfizer Investigational Site, Cerrahpasa / Istanbul
Pfizer Investigational Site, Çapa
Pfizer Investigational Site, Seville
Pfizer Investigational Site, Kaunas
Pfizer Investigational Site, Florence
Pfizer Investigational Site, Siena
Pfizer Investigational Site, Bonn
Pfizer Investigational Site, Pisa
Pfizer Investigational Site, Thessaloniki
Pfizer Investigational Site, Strasbourg
Pfizer Investigational Site, Foggia
Pfizer Investigational Site, San Luis Potosí City
Pfizer Investigational Site, Moscow
Pfizer Investigational Site, Moscow
Pfizer Investigational Site, Moscow
Pfizer Investigational Site, Saint Petersburg
Pfizer Investigational Site, Saint Petersburg
Pfizer Investigational Site, Saint Petersburg
Pfizer Investigational Site, Duffel
Pfizer Investigational Site, Yvoir
Pfizer Investigational Site, Kyustendil
Pfizer Investigational Site, Rousse
Pfizer Investigational Site, Montes de Oca
Pfizer Investigational Site, San José
Pfizer Investigational Site, Panama City
Pfizer Investigational Site, Brno
Pfizer Investigational Site, Hradec Králové
Pfizer Investigational Site, Olomouc
Pfizer Investigational Site, Ostrava-Trebovice
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Rychnov nad Kněžnou
Pfizer Investigational Site, Pune
Pfizer Investigational Site, Chandigarh
Pfizer Investigational Site, Ludhiana
Pfizer Investigational Site, Vilnius
Pfizer Investigational Site, Lima
Pfizer Investigational Site, Lima
Pfizer Investigational Site, Busan
Pfizer Investigational Site, Daejeon
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Seoul
Pfizer Investigational Site, Alicante
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, Ankara
Pfizer Investigational Site, Caracas
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY